Boris Pasche/LinkedIn
Mar 21, 2025, 15:09
Boris Pasche: Treatment of stage IV pancreatic cancer with the TheraBionic device
Boris Pasche, President and CEO of the Karmanos Cancer Institute, shared a post by Karmanos Cancer Institute on LinkedIn, adding:
“Patients diagnosed with pancreatic cancer have a new treatment option: Treatment of stage IV pancreatic cancer with the TheraBionic device.
Additionally, the TheraBionic device is available to patients with hepatocellular carcinoma who fail first line and second therapy.”
Quoting Karmanos Cancer Institute’s post below:
“Thank you to U CAN-CER VIVE for presenting our researchers with a donation to help further their studies looking at treatments for liver, pancreatic, colon, and breast cancers using radiofrequency electromagnetic fields!!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 10:04
Apr 15, 2025, 09:54
Apr 15, 2025, 09:48
Apr 15, 2025, 09:45
Apr 15, 2025, 09:37
Apr 15, 2025, 09:34
Apr 15, 2025, 09:30
Apr 15, 2025, 09:23
Apr 15, 2025, 09:02